Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
STERILE WATER vs PHYSIOSOL IN PLASTIC CONTAINER
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Water serves as a solvent and vehicle for drug administration; it has no intrinsic pharmacological activity.
PHYSIOSOL is a sterile, non-pyrogenic isotonic solution of electrolytes (sodium, potassium, calcium, magnesium, chloride, acetate, and gluconate) in water for injection. It serves as a source of water and electrolytes to expand extracellular fluid volume and maintain osmotic balance. The acetate and gluconate ions are metabolized to bicarbonate, providing an alkalinizing effect.
Reconstitution of powdered medications,Dilution of intravenous medications,Flushing of intravenous lines,Hydration (when combined with electrolytes)
Intravenous solution for fluid and electrolyte replacement in patients with isotonic or hypotonic dehydration,Maintenance of fluid and electrolyte balance during surgery or in postoperative patients,Vehicle for administration of compatible medications
50-100 m L intravenous bolus as a vehicle for drug reconstitution or for hydration; frequency as needed for specific clinical indication.
Intravenous infusion; dose based on fluid and electrolyte requirements; typical adult dose: 500-1000 m L/h as needed to maintain hydration and electrolyte balance.
1.5–3.5 hours; water turnover depends on physiological state; clinical context: equilibrates rapidly with total body water
Not applicable (physiologic solution); infused electrolytes and water distribute and are eliminated with kinetics dependent on renal function; terminal half-life reflects water turnover (~3-6 days in healthy adults).
Not metabolized; excreted unchanged primarily by the kidneys.
The acetate and gluconate ions are metabolized in the liver and peripheral tissues, primarily via the tricarboxylic acid cycle, to bicarbonate. Electrolytes (sodium, potassium, calcium, magnesium, chloride) are not metabolized but are excreted or reabsorbed as per physiological needs.
Renal: >99% as water; fecal: negligible; biliary: negligible
Renal excretion of water and electrolytes; >95% of administered volume is excreted unchanged by kidneys within 24 hours; minimal (<5%) fecal or biliary elimination.
0% (water is not protein-bound)
Negligible (<1%); electrolytes are not bound to plasma proteins.
0.6 L/kg (approximates total body water; Vd ~42 L in 70 kg adult)
Approximately 0.55 L/kg (total body water); distributes into extracellular fluid (0.2 L/kg) and intracellular water (0.4 L/kg).
Intravenous: 100%; Oral: >95% (essentially complete absorption)
Intravenous: 100%; oral: 100% (but not relevant as product is for IV use only).
No dose adjustment required; however, careful monitoring of fluid balance in patients with renal impairment to avoid fluid overload.
No dose adjustment required; monitor serum electrolytes and fluid balance closely in renal impairment; adjust infusion rate based on renal function to avoid fluid overload.
No dose adjustment required; sterile water does not undergo hepatic metabolism.
No specific dose adjustment required; monitor serum electrolytes and acid-base balance in severe hepatic impairment.
Dose based on patient weight and clinical need; typical fluid maintenance: 100 m L/kg/day for first 10 kg, plus 50 m L/kg/day for next 10 kg, plus 20 m L/kg/day for weight above 20 kg; administered intravenously.
Intravenous infusion; dosing based on body weight; typical dose: 10-20 m L/kg for acute replacement, then adjust based on maintenance requirements; monitor electrolyte levels.
Use with caution due to potential for fluid overload; adjust volume based on renal function and cardiovascular status; typical starting dose 25-50 m L intravenous bolus.
Use with caution; start with lower end of dosing range; monitor for fluid overload, electrolyte disturbances, and renal function due to age-related changes.
None.
Not for injection into the epidural, intrathecal, or intra-arterial spaces. Do not administer if solution contains visible particulate matter or is discolored. Use only if solution is clear and container is undamaged.
Use only sterile water for injection; hypotension and electrolyte disturbances if used in large volumes without electrolytes; hemolysis if administered intravenously without isotonicity.
Monitor serum electrolytes, fluid balance, and renal function during prolonged therapy,Use with caution in patients with heart failure, renal impairment, or conditions predisposing to fluid overload,Avoid rapid administration to prevent hypervolemia and electrolyte disturbances,Contains potassium; use cautiously in patients with hyperkalemia or conditions predisposing to potassium retention,Contains calcium; do not administer simultaneously with blood products through the same IV line due to risk of precipitation
Hypersensitivity to any component; do not use for intravenous injection without first making isotonic by adding solutes (except for reconstitution followed by dilution).
Hypersensitivity to any component of the solution,Hyperkalemia,Hypercalcemia,Severe metabolic alkalosis,Patients with significant fluid overload or pulmonary edema,Concomitant administration with blood products via same IV line
No known food interactions.
No specific food interactions. However, consider overall fluid and electrolyte intake from diet, especially sodium and potassium, to avoid imbalances.
No known teratogenic effects in any trimester; sterile water is not pharmacologically active and does not cross the placenta in quantities that would produce fetal effects. Risk classification: FDA Category A (if considered a drug) or generally recognized as safe.
Physiosol in plastic container is a sterile, non-pyrogenic isotonic solution of electrolytes and water. It contains no known teratogenic agents. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been conducted with this solution. Therefore, it should be used during pregnancy only if clearly needed. No specific fetal risks have been identified for any trimester when used as directed.
Compatible with breastfeeding; water is a normal constituent of breast milk and maternal administration does not increase risk. M/P ratio: 1.0 (approximate, as water distributes equally in body fluids).
Safety in breastfeeding has not been established. Since Physiosol is a balanced electrolyte solution, it is unlikely to pose significant risk to the nursing infant. However, caution is advised. The milk-to-plasma (M/P) ratio is not available.
No dose adjustment required; pharmacokinetics of water are unchanged in pregnancy. Standard dosing based on clinical need (e.g., hydration, dilution of medications).
No specific dosing adjustments are required for pregnancy based on pharmacokinetic changes. However, pregnant patients may have increased plasma volume, and fluid and electrolyte requirements should be individualized. Caution is advised in preeclampsia or conditions with fluid overload.
Sterile water is used for dilution or reconstitution of medications before injection. It is not for direct intravenous administration without tonicity adjustment. Use within 2 hours after opening to minimize contamination risk.
Physiosol in plastic container is a balanced electrolyte solution for intravenous administration, primarily used for replacement of extracellular fluid losses. Monitor for signs of fluid overload, especially in patients with heart failure or renal impairment. The plastic container may leach phthalates; use with caution in neonates and pregnant women. Do not administer if solution is discolored or contains particulate matter.
This product is not for direct injection; it must be mixed with medication by a healthcare professional.,Do not use if solution is cloudy or contains particulates.,Store at room temperature away from moisture and heat.
This solution is given intravenously to replace fluids and electrolytes.,Report any signs of allergic reaction, such as rash, itching, or difficulty breathing.,Notify your healthcare provider if you experience swelling, shortness of breath, or rapid weight gain.,Do not stop the infusion without consulting your doctor.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about STERILE WATER vs PHYSIOSOL IN PLASTIC CONTAINER, answered by our medical review team.
STERILE WATER is a Irrigation Solution that works by Water serves as a solvent and vehicle for drug administration; it has no intrinsic pharmacological activity.. PHYSIOSOL IN PLASTIC CONTAINER is a Irrigation Solution that works by PHYSIOSOL is a sterile, non-pyrogenic isotonic solution of electrolytes (sodium, potassium, calcium, magnesium, chloride, acetate, and gluconate) in water for injection. It serves as a source of water and electrolytes to expand extracellular fluid volume and maintain osmotic balance. The acetate and gluconate ions are metabolized to bicarbonate, providing an alkalinizing effect.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between STERILE WATER and PHYSIOSOL IN PLASTIC CONTAINER depend on the specific clinical indication. These are both Irrigation Solution agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of STERILE WATER is: 50-100 m L intravenous bolus as a vehicle for drug reconstitution or for hydration; frequency as needed for specific clinical indication.. The standard adult dose of PHYSIOSOL IN PLASTIC CONTAINER is: Intravenous infusion; dose based on fluid and electrolyte requirements; typical adult dose: 500-1000 m L/h as needed to maintain hydration and electrolyte balance.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between STERILE WATER and PHYSIOSOL IN PLASTIC CONTAINER in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. STERILE WATER is classified as Category C. No known teratogenic effects in any trimester; sterile water is not pharmacologically active and does not cross the placenta in quantities that would produce fetal effects. Risk cl. PHYSIOSOL IN PLASTIC CONTAINER is classified as Category C. Physiosol in plastic container is a sterile, non-pyrogenic isotonic solution of electrolytes and water. It contains no known teratogenic agents. There are no adequate and well-cont. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.